Quantitative measurements of medical images for pharmaceutical clinical trials: Comparison between on-site and off-site assessments

American Journal of Roentgenology

Volumn 174, Issue 4, 2000, Pages 1159-1162

  Sahani, Dushyant ^a   Saini, Sanjay ^a   Fatuga, Gbolahan A ^b   Halpern, Elkan F ^a   Lanser, Marc E ^c   Zimmerman, Jay B ^b   Fischman, Alan J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WorldCare Inc   (United States)

^c Boston Life Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTROPANE; ALTROPANE I 123; CONTRAST MEDIUM; DOPAMINE TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG PROTEIN BINDING; DRUG RESEARCH; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RELIABILITY; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034083918     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.174.4.1741159     Document Type: Article

References (13)

1. Houston AS, Kemp PM, Macleod MA. Optimization of factors affecting the state of normality of a medical image. Phys Med Biol 1996;41:755-765
2. Schenone A, Firenze F, Acquarone F, Gambaro M, Masulli F, Andreucci L. Segmentation of multivariate medical images via unsupervised clustering with "adaptive resolution." Comput Med Imaging Graph 1996;20:119-129
3. Acton PD, Pilowsky LS, Costa DC, Ell PJ. Multivariate clustering analysis of dynamic iodine-123 iodobenzamide SPECT dopamine D2 receptor images in schizophrenia. Eur J Nucl Med 1997; 24:111-118
4. Madras BK, Meltzer PC, Liang AY, Elmaleh DR, Babich J, Fishman AJ. Altropane, a SPECT or PET imaging probe for dopamine neurons. I. Dopamine transporter binding in primate brain. Synapse 1998;29:93-104
5. Fischman AJ, Babich JW, Elmaleh DR, et al. SPECT imaging of dopamine transporter sites in normal and MPTP-treated rhesus monkeys. J Nucl Med 1997;38:144-150
6. Fischman AJ, Bonab AA, Babich JW, et al. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporter. Synapse 1998;29:128-141
7. Madras BK, Gracz LM, Meltzer PC, et al. Altropane, a SPECT or PET imaging probe for dopamine neurons. II. Distribution to dopamine-rich regions of primate brain. Synapse 1998;29:105-115
8. Chang L. A method for attenuation correction in computed tomography. IEEE Trans Nucl Sci 1987; 25:638-643
9. Madras BK, Gracz LM, Fahey MA, et al. Altropane, a SPECT or PET imaging probe for dopamine neurons. III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain. Synapse 1998;29:116-127
10. Ishikawa T, Dhawan V, Kazumata K, et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med 1996;37:1760-1765
11. Morris E, Babich J, Alpert N, et al. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT. Synapse 1996;24:262-272
12. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15:217-227
13. Farde L, Eriksson L, Blomquist G, Hallidin C. Kinetic analysis of central [11C] Raclopride binding to D2-dopamine receptors studied by PET: comparison to equilibrium analysis. J Cereb Blood Flow Metab 1989;9:696-708